Once-daily Fixed Combination of Three Antihypertensive Drugs

NCT02710539 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-03-16

No results posted yet for this study

Summary

Randomized comparison of once-daily fixed combiNation versus free-drug combination of three antihypertensive agents in arterial hypertension

Conditions

  • Arterial Hypertension

Interventions

DRUG

perindopril, indapamide , amlodipine

Free combination of perindopril 10 mg, indapamide 2,5 mg, amlodipine 10 mg

DRUG

Tripliam (perindopril, indapamide, amlodipine)

Fixed combination of perindopril 10 mg, indapamide 2,5 mg, amlodipine 10 mg

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Carlo Gaudio, MD · Sapienza University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-03-31
Completion
2020-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02710539 on ClinicalTrials.gov